Article(id=1329914432194458402, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914419489911429, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2024.04.002, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1704297600000, receivedDateStr=2024-01-04, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795005909250, onlineDateStr=2026-11-18, pubDate=1712678400000, pubDateStr=2024-04-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795005909250, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795005909250, creator=13701087609, updateTime=1795005909250, updator=13701087609, issue=Issue{id=1329914419489911429, tenantId=1146029695717560320, journalId=1319690259887390882, year='2024', volume='55', issue='4', pageStart='445', pageEnd='591', issueExtLink='null', onlineDate='null', pubDate='1712678400000', pubDateStr='2024-04-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795005906221, creator='13701087609', updateTime=1795136111536, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330460540603839226, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914419489911429, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330460540603839227, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914419489911429, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=456, endPage=462, ext={EN=ArticleExt(id=1329914432399979299, articleId=1329914432194458402, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=A Brief Analysis of Pharmaceutical Research and Evaluation of Nanocrystal Pharmaceutical Products, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Nanocrystal pharmaceutical products can significantly improve drug solubility and bioavailability. Several products have been marketed globally, but domestic and foreign regulatory agencies have not yet formed a clear and unified regulatory assessment program for them. This review introduces the regulation and listing of some nanocrystal pharmaceutical products marketed at home and abroad, discusses the pharmaceutical research and evaluation from the aspects of API, excipients, production process, quality research and control, packaging materials and stability, and analyzes them with case studies, in order to provide a reference for the pharmaceutical research and evaluation of nanocrystal pharmaceutical products.

, authors=Liu YANG, Junlin ZHANG, Yongping SHI, Zhenyu XU*, authorsList=Liu YANG, Junlin ZHANG, Yongping SHI, Zhenyu XU, authorCompany=null, correspAuthors=Zhenyu XU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329914433276588836, articleId=1329914432194458402, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=浅谈纳米晶药物的药学研究与评价, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

纳米晶药物可显著改善药物的溶解度和生物利用度。目前已有多个纳米晶药物在全球上市,但国内外监管机构尚未针对纳米晶药物形成明确、统一的监管评估方案。该文对国内外纳米晶药物的监管及上市情况进行了介绍,从纳米晶药物的原料药、辅料、生产工艺、质量研究与控制、包材与稳定性等方面,对纳米晶药物的药学研究与评价进行探讨,并结合案例进行分析,以期为纳米晶药物的药学研究与评价提供参考。

, authors=杨柳, 章俊麟, 石勇平, 许真玉*, authorsList=杨柳, 章俊麟, 石勇平, 许真玉, authorCompany=null, correspAuthors=许真玉, authorNote=

杨柳(1985—),女,硕士,审评员,从事化学药品技术审评工作。

, correspAuthorsNote=
许真玉(1975—),女,博士,主任药师,从事化学药品技术审评工作。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=qMhfsj3KK7Y3rjjlxJ2zUw==, magXml=oUO4ieuCNoSn1My2D1hEAA==, pdfUrl=null, pdf=pqK/3QkH2WHvVMUd2gnWVQ==, pdfFileSize=1769075, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=VRMuiRxW6gDrhQmlcQAHtw==, mapNumber=null, fund=null)}, authors=[Author(id=1329914971703587360, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914971787473442, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, authorId=1329914971703587360, language=EN, stringName=Liu YANG, firstName=Liu, middleName=null, lastName=YANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914971858776611, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, authorId=1329914971703587360, language=CN, stringName=杨柳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100076, bio={"content":"

杨柳(1985—),女,硕士,审评员,从事化学药品技术审评工作。

"}, bioImg=null, bioContent=

杨柳(1985—),女,硕士,审评员,从事化学药品技术审评工作。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914971602924060, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, xref=null, ext=[AuthorCompanyExt(id=1329914971615506973, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, companyId=1329914971602924060, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076), AuthorCompanyExt(id=1329914971623895582, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, companyId=1329914971602924060, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100076)])]), Author(id=1329914971917496869, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914971988800039, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, authorId=1329914971917496869, language=EN, stringName=Junlin ZHANG, firstName=Junlin, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914972051714600, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, authorId=1329914971917496869, language=CN, stringName=章俊麟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914971602924060, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, xref=null, ext=[AuthorCompanyExt(id=1329914971615506973, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, companyId=1329914971602924060, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076), AuthorCompanyExt(id=1329914971623895582, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, companyId=1329914971602924060, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100076)])]), Author(id=1329914972110434858, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914972181738028, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, authorId=1329914972110434858, language=EN, stringName=Yongping SHI, firstName=Yongping, middleName=null, lastName=SHI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914972248846893, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, authorId=1329914972110434858, language=CN, stringName=石勇平, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914971602924060, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, xref=null, ext=[AuthorCompanyExt(id=1329914971615506973, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, companyId=1329914971602924060, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076), AuthorCompanyExt(id=1329914971623895582, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, companyId=1329914971602924060, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100076)])]), Author(id=1329914972315955759, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=xuzhy@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329914972387258929, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, authorId=1329914972315955759, language=EN, stringName=Zhenyu XU, firstName=Zhenyu, middleName=null, lastName=XU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914972521476658, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, authorId=1329914972315955759, language=CN, stringName=许真玉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=国家药品监督管理局药品审评中心,北京 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914971602924060, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, xref=null, ext=[AuthorCompanyExt(id=1329914971615506973, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, companyId=1329914971602924060, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076), AuthorCompanyExt(id=1329914971623895582, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, companyId=1329914971602924060, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100076)])])], keywords=[Keyword(id=1329914972655694387, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, language=EN, orderNo=1, keyword=nanocrystal), Keyword(id=1329914972743774772, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, language=EN, orderNo=2, keyword=nanomedicine), Keyword(id=1329914972806689333, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, language=EN, orderNo=3, keyword=pharmaceutical research), Keyword(id=1329914972865409590, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, language=EN, orderNo=4, keyword=evaluation), Keyword(id=1329914972928324151, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, language=CN, orderNo=1, keyword=纳米晶), Keyword(id=1329914972991238712, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, language=CN, orderNo=2, keyword=纳米药物), Keyword(id=1329914973075124793, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, language=CN, orderNo=3, keyword=药学研究), Keyword(id=1329914973133845050, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, language=CN, orderNo=4, keyword=评价)], refs=[Reference(id=1329914973305811515, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=JIA Y C, JIANG Y X, HE Y L, et al.Approved nanomedicine against diseases [J].Pharmaceutics, 2023, 15(3): 774., articleTitle=null, refAbstract=null), Reference(id=1329914973377114684, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=王若楠,袁鹏辉,杨德智,等.纳米晶药物的应用及展望[J].医药导报,2020,39(8):1100-1106., articleTitle=null, refAbstract=null), Reference(id=1329914973461000765, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=CHENG Z Y, LIAN Y M, KAMAL Z, et al.Nanocrystals technology for pharmaceutical science [J].Curr Pharm Des, 2018, 24(21): 2497-2507., articleTitle=null, refAbstract=null), Reference(id=1329914973519721022, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=JUNGHANNS J A H, MÜLLER R H.Nanocrystal technology, drug delivery and clinical applications [J].Int J Nanomedicine, 2008, 3(3): 295-309., articleTitle=null, refAbstract=null), Reference(id=1329914973578441279, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN M L, JOHN M, LEE S L, et al.Development considerations for nanocrystal drug products [J].AAPS J, 2017, 19(3): 642-651., articleTitle=null, refAbstract=null), Reference(id=1329914973641355840, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=HE Y, YE Z Y F, LIU X Y, et al.Can machine learning predict drug nanocrystals? [J].J Control Release, 2020, 322: 274-285., articleTitle=null, refAbstract=null), Reference(id=1329914973716853313, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG Y, TAN X Y, FAN X Y, et al.Current strategies for oral delivery of BCSⅣ drug nanocrystals: challenges, solutions and future trends [J].Expert Opin Drug Deliv, 2021, 18(9): 1211-1228., articleTitle=null, refAbstract=null), Reference(id=1329914973783962178, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.纳米药物质量控制研究技术指导原则(试行)[EB/OL].(2021-08-27)[2023-12-30].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=3e60526d467585dc77d-35445f04bae5c., articleTitle=null, refAbstract=null), Reference(id=1329914973851071043, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.化学仿制药晶型研究技术指导原则(试行)[EB/OL].(2022-01-04)[2023-12-30].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=9c628f356cbaa79302e2d-8149c187ec2., articleTitle=null, refAbstract=null), Reference(id=1329914973918179908, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=章俊麟,许真玉,代文兵,等.阿立哌唑长效注射剂研究进展[J].中国医药工业杂志,2019,50(10):1153-1159., articleTitle=null, refAbstract=null), Reference(id=1329914973989483077, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU Y Q, DU J, WANG L L, et al.Nanocrystals technology for improving bioavailability of poorly soluble drugs: a mini-review [J].J Nanosci Nanotechnol, 2017, 17(1): 18-28., articleTitle=null, refAbstract=null), Reference(id=1329914974056591942, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=岳鹏飞,王勇,万晶,等.固体纳米晶体给药系统构建方法的研究进展[J].药学学报,2012,47(9):1120-1127., articleTitle=null, refAbstract=null), Reference(id=1329914974136283719, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=COUILLAUD B M, ESPEAU P, MIGNET N, et al.State of the art of pharmaceutical solid forms: from crystal property issues to nanocrystals formulation [J].ChemMedChem, 2019, 14(1): 8-23., articleTitle=null, refAbstract=null), Reference(id=1329914974207586888, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=UEDA K, IWAI T, SUNAZUKA Y, et al.Effect of molecular weight of hypromellose on mucin diffusion and oral absorption behavior of fenofibrate nanocrystal [J].Int J Pharm, 2019, 564: 39-47., articleTitle=null, refAbstract=null), Reference(id=1329914974266307145, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=LI J R, WANG Z M, ZHANG H, et al.Progress in the development of stabilization strategies for nanocrystal preparations [J].Drug Deliv, 2021, 28(1): 19-36., articleTitle=null, refAbstract=null), Reference(id=1329914974325027402, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=MÖSCHWITZER J P.Drug nanocrystals in the commercial pharmaceutical development process [J].Int J Pharm, 2013, 453(1): 142-156., articleTitle=null, refAbstract=null), Reference(id=1329914974383747659, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=DE WAARD H, FRIJLINK H W, HINRICHS W L J.Bottom-up preparation techniques for nanocrystals of lipophilic drugs [J].Pharm Res, 2011, 28(5): 1220-1223., articleTitle=null, refAbstract=null), Reference(id=1329914974442467916, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=MERISKO-LIVERSIDGE E, LIVERSIDGE G G.Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology [J].Adv Drug Deliv Rev, 2011, 63(6): 427-440., articleTitle=null, refAbstract=null), Reference(id=1329914974509576781, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Emend: clinical pharmacology biopharmaceutics review(s) [EB/OL].(2003-03-26)[2023-12-30].https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-549_Emend_biopharmr.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914974568297038, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Emend: chemistry review(s)[EB/OL].(2003-03-26)[2023-12-30].https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-549_Emend_chemr.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914974631211599, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.Emend [EB/OL].[2023-12-30].https://www.ema.europa.eu/en/documents/scientific-discussion/emend-epar-scientific-discussion_en.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914974698320464, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=OLVER I, SHELUKAR S, THOMPSON K C.Nanomedicines in the treatment of emesis during chemotherapy focus on aprepitant [J].Int J Nanomedicine, 2007, 2(1): 13-18., articleTitle=null, refAbstract=null), Reference(id=1329914974752846417, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=默沙东有限责任公司.速激肽受体拮抗剂的药用纳米粒组合物:中国,100352443C [P].2007-12-05., articleTitle=null, refAbstract=null), Reference(id=1329914974811566674, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=MERISKO-LIVERSIDGE E, LIVERSIDGE G G, COOPER E R.Nanosizing: a formulation approach for poorly-water-soluble compounds soluble compounds [J].Eur J Pharm Sci, 2003, 18(2): 113-120., articleTitle=null, refAbstract=null), Reference(id=1329914974866092627, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Guidance on aprepitant [EB/OL].[2023-12-30].https://www.accessdata.fda.gov/drugsatfda_docs/psg/Aprepitant_cap_21549_RC10-05.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914974916424276, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Ryanodex: clinical pharmacology biopharmaceutics review(s) [EB/OL].(2014-07-22)[2023-12-30].https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205579Orig1s000ClinPharmR.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914974970950229, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Ryanodex: chemistry review(s) [EB/OL].(2014-07-22)[2023-12-30].https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205579Orig1s000ChemR.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914975042253398, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Draft guidance on dantrolene sodium [EB/OL].(2022-08)[2023-12-30].https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_205579.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914975105167959, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=司晓菲,那馨竹,章俊麟,等.棕榈酸帕利哌酮长效注射剂仿制药药学研究探究[J].中国临床药理学杂志,2023,39(9):1359-1363., articleTitle=null, refAbstract=null), Reference(id=1329914975159693912, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Invega Sustenna: chemistry review(s) [EB/OL].(2009-07-31)[2023-12-30].https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022264s000chemr.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914975226802777, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Invega Trinza: chemistry review(s) [EB/OL].(2015-05-18)[2023-12-30].https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/207946Orig1s000ChemR.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914975293911642, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Draft guidance on paliperidone palmitate [EB/OL].[2023-12-30].https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_207946.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914975390380635, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Draft guidance on paliperidone palmitate [EB/OL].[2023-12-30].https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_022264.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914975461683804, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=TYNER K M, ZHENG N, CHOI S, et al.How has CDER prepared for the nano revolution? A review of risk assessment, regulatory research, and guidance activities [J].AAPS J, 2017, 19(4): 1071-1083., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329914971602924060, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, xref=null, ext=[AuthorCompanyExt(id=1329914971615506973, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, companyId=1329914971602924060, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076), AuthorCompanyExt(id=1329914971623895582, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, companyId=1329914971602924060, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100076)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.04.002, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.04.002, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2024.04.002, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2024.04.002, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1712678400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
浅谈纳米晶药物的药学研究与评价
杨柳 , 章俊麟 , 石勇平 , 许真玉 *
中国医药工业杂志 | 综述 2024,55(4): 456-462
收起
收藏切换
中国医药工业杂志 |综述 2024 , 55 (4) : 456 -462
浅谈纳米晶药物的药学研究与评价
全屏
[Author(id=1329914971703587360, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914971787473442, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, authorId=1329914971703587360, language=EN, stringName=Liu YANG, firstName=Liu, middleName=null, lastName=YANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914971858776611, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, authorId=1329914971703587360, language=CN, stringName=杨柳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100076, bio={"content":"

杨柳(1985—),女,硕士,审评员,从事化学药品技术审评工作。

"}, bioImg=null, bioContent=

杨柳(1985—),女,硕士,审评员,从事化学药品技术审评工作。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914971602924060, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, xref=null, ext=[AuthorCompanyExt(id=1329914971615506973, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, companyId=1329914971602924060, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076), AuthorCompanyExt(id=1329914971623895582, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, companyId=1329914971602924060, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100076)])]), Author(id=1329914971917496869, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914971988800039, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, authorId=1329914971917496869, language=EN, stringName=Junlin ZHANG, firstName=Junlin, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914972051714600, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, authorId=1329914971917496869, language=CN, stringName=章俊麟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914971602924060, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, xref=null, ext=[AuthorCompanyExt(id=1329914971615506973, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, companyId=1329914971602924060, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076), AuthorCompanyExt(id=1329914971623895582, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, companyId=1329914971602924060, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100076)])]), Author(id=1329914972110434858, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914972181738028, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, authorId=1329914972110434858, language=EN, stringName=Yongping SHI, firstName=Yongping, middleName=null, lastName=SHI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914972248846893, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, authorId=1329914972110434858, language=CN, stringName=石勇平, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914971602924060, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, xref=null, ext=[AuthorCompanyExt(id=1329914971615506973, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, companyId=1329914971602924060, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076), AuthorCompanyExt(id=1329914971623895582, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, companyId=1329914971602924060, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100076)])]), Author(id=1329914972315955759, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=xuzhy@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329914972387258929, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, authorId=1329914972315955759, language=EN, stringName=Zhenyu XU, firstName=Zhenyu, middleName=null, lastName=XU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914972521476658, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, authorId=1329914972315955759, language=CN, stringName=许真玉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=国家药品监督管理局药品审评中心,北京 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914971602924060, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, xref=null, ext=[AuthorCompanyExt(id=1329914971615506973, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, companyId=1329914971602924060, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076), AuthorCompanyExt(id=1329914971623895582, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914432194458402, companyId=1329914971602924060, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100076)])])]
杨柳, 章俊麟, 石勇平, 许真玉*
作者信息
  • 国家药品监督管理局药品审评中心,北京 100076
通讯作者:
许真玉(1975—),女,博士,主任药师,从事化学药品技术审评工作。E-mail:
作者简介:

杨柳(1985—),女,硕士,审评员,从事化学药品技术审评工作。

A Brief Analysis of Pharmaceutical Research and Evaluation of Nanocrystal Pharmaceutical Products
Liu YANG, Junlin ZHANG, Yongping SHI, Zhenyu XU*
Affiliations
  • Center for Drug Evaluation, National Medical Products Administration, Beijing 100076
出版时间: 2024-04-10 doi: 10.16522/j.cnki.cjph.2024.04.002
文章导航
收藏切换

纳米晶药物可显著改善药物的溶解度和生物利用度。目前已有多个纳米晶药物在全球上市,但国内外监管机构尚未针对纳米晶药物形成明确、统一的监管评估方案。该文对国内外纳米晶药物的监管及上市情况进行了介绍,从纳米晶药物的原料药、辅料、生产工艺、质量研究与控制、包材与稳定性等方面,对纳米晶药物的药学研究与评价进行探讨,并结合案例进行分析,以期为纳米晶药物的药学研究与评价提供参考。

纳米晶  /  纳米药物  /  药学研究  /  评价

Nanocrystal pharmaceutical products can significantly improve drug solubility and bioavailability. Several products have been marketed globally, but domestic and foreign regulatory agencies have not yet formed a clear and unified regulatory assessment program for them. This review introduces the regulation and listing of some nanocrystal pharmaceutical products marketed at home and abroad, discusses the pharmaceutical research and evaluation from the aspects of API, excipients, production process, quality research and control, packaging materials and stability, and analyzes them with case studies, in order to provide a reference for the pharmaceutical research and evaluation of nanocrystal pharmaceutical products.

nanocrystal  /  nanomedicine  /  pharmaceutical research  /  evaluation
杨柳, 章俊麟, 石勇平, 许真玉. 浅谈纳米晶药物的药学研究与评价. 中国医药工业杂志, 2024 , 55 (4) : 456 -462 . DOI: 10.16522/j.cnki.cjph.2024.04.002
Liu YANG, Junlin ZHANG, Yongping SHI, Zhenyu XU. A Brief Analysis of Pharmaceutical Research and Evaluation of Nanocrystal Pharmaceutical Products[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (4) : 456 -462 . DOI: 10.16522/j.cnki.cjph.2024.04.002

参考文献 引证文献
排序方式:
[1]
JIA Y C, JIANG Y X, HE Y L, et al.Approved nanomedicine against diseases [J].Pharmaceutics, 2023, 15(3): 774.
[2]
王若楠,袁鹏辉,杨德智,等.纳米晶药物的应用及展望[J].医药导报,2020,39(8):1100-1106.
[3]
CHENG Z Y, LIAN Y M, KAMAL Z, et al.Nanocrystals technology for pharmaceutical science [J].Curr Pharm Des, 2018, 24(21): 2497-2507.
[4]
JUNGHANNS J A H, MÜLLER R H.Nanocrystal technology, drug delivery and clinical applications [J].Int J Nanomedicine, 2008, 3(3): 295-309.
[5]
CHEN M L, JOHN M, LEE S L, et al.Development considerations for nanocrystal drug products [J].AAPS J, 2017, 19(3): 642-651.
[6]
HE Y, YE Z Y F, LIU X Y, et al.Can machine learning predict drug nanocrystals? [J].J Control Release, 2020, 322: 274-285.
[7]
WANG Y, TAN X Y, FAN X Y, et al.Current strategies for oral delivery of BCSⅣ drug nanocrystals: challenges, solutions and future trends [J].Expert Opin Drug Deliv, 2021, 18(9): 1211-1228.
[8]
国家药品监督管理局药品审评中心.纳米药物质量控制研究技术指导原则(试行)[EB/OL].(2021-08-27)[2023-12-30].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=3e60526d467585dc77d-35445f04bae5c.
[9]
国家药品监督管理局药品审评中心.化学仿制药晶型研究技术指导原则(试行)[EB/OL].(2022-01-04)[2023-12-30].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=9c628f356cbaa79302e2d-8149c187ec2.
[10]
章俊麟,许真玉,代文兵,等.阿立哌唑长效注射剂研究进展[J].中国医药工业杂志,2019,50(10):1153-1159.
[11]
ZHOU Y Q, DU J, WANG L L, et al.Nanocrystals technology for improving bioavailability of poorly soluble drugs: a mini-review [J].J Nanosci Nanotechnol, 2017, 17(1): 18-28.
[12]
岳鹏飞,王勇,万晶,等.固体纳米晶体给药系统构建方法的研究进展[J].药学学报,2012,47(9):1120-1127.
[13]
COUILLAUD B M, ESPEAU P, MIGNET N, et al.State of the art of pharmaceutical solid forms: from crystal property issues to nanocrystals formulation [J].ChemMedChem, 2019, 14(1): 8-23.
[14]
UEDA K, IWAI T, SUNAZUKA Y, et al.Effect of molecular weight of hypromellose on mucin diffusion and oral absorption behavior of fenofibrate nanocrystal [J].Int J Pharm, 2019, 564: 39-47.
[15]
LI J R, WANG Z M, ZHANG H, et al.Progress in the development of stabilization strategies for nanocrystal preparations [J].Drug Deliv, 2021, 28(1): 19-36.
[16]
MÖSCHWITZER J P.Drug nanocrystals in the commercial pharmaceutical development process [J].Int J Pharm, 2013, 453(1): 142-156.
[17]
DE WAARD H, FRIJLINK H W, HINRICHS W L J.Bottom-up preparation techniques for nanocrystals of lipophilic drugs [J].Pharm Res, 2011, 28(5): 1220-1223.
[18]
MERISKO-LIVERSIDGE E, LIVERSIDGE G G.Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology [J].Adv Drug Deliv Rev, 2011, 63(6): 427-440.
[19]
FDA.Emend: clinical pharmacology biopharmaceutics review(s) [EB/OL].(2003-03-26)[2023-12-30].https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-549_Emend_biopharmr.pdf.
[20]
FDA.Emend: chemistry review(s)[EB/OL].(2003-03-26)[2023-12-30].https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-549_Emend_chemr.pdf.
[22]
OLVER I, SHELUKAR S, THOMPSON K C.Nanomedicines in the treatment of emesis during chemotherapy focus on aprepitant [J].Int J Nanomedicine, 2007, 2(1): 13-18.
[23]
默沙东有限责任公司.速激肽受体拮抗剂的药用纳米粒组合物:中国,100352443C [P].2007-12-05.
[24]
MERISKO-LIVERSIDGE E, LIVERSIDGE G G, COOPER E R.Nanosizing: a formulation approach for poorly-water-soluble compounds soluble compounds [J].Eur J Pharm Sci, 2003, 18(2): 113-120.
[25]
FDA.Guidance on aprepitant [EB/OL].[2023-12-30].https://www.accessdata.fda.gov/drugsatfda_docs/psg/Aprepitant_cap_21549_RC10-05.pdf.
[26]
FDA.Ryanodex: clinical pharmacology biopharmaceutics review(s) [EB/OL].(2014-07-22)[2023-12-30].https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205579Orig1s000ClinPharmR.pdf.
[27]
FDA.Ryanodex: chemistry review(s) [EB/OL].(2014-07-22)[2023-12-30].https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205579Orig1s000ChemR.pdf.
[28]
FDA.Draft guidance on dantrolene sodium [EB/OL].(2022-08)[2023-12-30].https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_205579.pdf.
[29]
司晓菲,那馨竹,章俊麟,等.棕榈酸帕利哌酮长效注射剂仿制药药学研究探究[J].中国临床药理学杂志,2023,39(9):1359-1363.
[30]
FDA.Invega Sustenna: chemistry review(s) [EB/OL].(2009-07-31)[2023-12-30].https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022264s000chemr.pdf.
[31]
FDA.Invega Trinza: chemistry review(s) [EB/OL].(2015-05-18)[2023-12-30].https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/207946Orig1s000ChemR.pdf.
[32]
FDA.Draft guidance on paliperidone palmitate [EB/OL].[2023-12-30].https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_207946.pdf.
[33]
FDA.Draft guidance on paliperidone palmitate [EB/OL].[2023-12-30].https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_022264.pdf.
[34]
TYNER K M, ZHENG N, CHOI S, et al.How has CDER prepared for the nano revolution? A review of risk assessment, regulatory research, and guidance activities [J].AAPS J, 2017, 19(4): 1071-1083.
2024年第55卷第4期
22
5
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2024.04.002
  • 接收时间:2024-01-04
  • 首发时间:2026-11-18
  • 出版时间:2024-04-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-01-04
基金
作者信息
    国家药品监督管理局药品审评中心,北京 100076

通讯作者:

许真玉(1975—),女,博士,主任药师,从事化学药品技术审评工作。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.04.002
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏